Skip to main content

Market Overview

Cell Therapeutics, Inc. (NASDAQ: CTIC)

2.31 -0.09 (-3.75%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/06/21StifelInitiates Coverage OnBuy5.5
10/23/20Brookline CapitalInitiates Coverage OnBuy7.0
9/30/20NeedhamMaintainsBuy6.0
3/05/19Lake StreetInitiates Coverage OnBuy
3/07/18JMP SecuritiesInitiates Coverage OnOutperform8.0
2/23/18OppenheimerInitiates Coverage OnOutperform5.0
9/12/17JefferiesInitiates Coverage OnBuy7.5
2/10/16WallachBeth CapitalDowngradesSell
2/10/16Piper SandlerDowngradesNeutral0.750
11/09/15WallachBeth CapitalDowngradesHold

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter